NCT02575625View on ClinicalTrials.gov

Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis

NAUnknownINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Liver Steatosis
Interventions
DEVICE

Fibroscan

Three series oh independent measures Measure done with Fibroscan will be preceded by tracking ultrasonography.

BIOLOGICAL

Blood test for biological assessment of liver function

Blood test for biological assessment of liver function

DEVICE

MRI

Liver MRI

Trial Locations (1)

37044

RECRUITING

University Hospital of Tours, Tours

Sponsors

Collaborators (1)

Echosens
All Listed Sponsors
collaborator

Echosens

INDUSTRY

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Tours

OTHER

NCT02575625 - Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis | Biotech Hunter | Biotech Hunter